World

Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain

In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases and 4,600 fatalities since May.